LMN PHARMACIST: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LMN PHARMACIST
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Other debts +€88,953
up €88,953 (+103%), from €86,436 to €175,389
- Debts after one year -€43,111
down €43,111 (-8.6%), from €500,211 to €457,100
- Tax, wage and social debts -€33,108
down €33,108 (-88.3%), from €37,494 to €4,386
- Profit (loss) carried forward -€16,634
down €16,634 (-12.3%), from €135,373 to €118,739
- Gross operating margin -€60,532
down €60,532, from €57,628 to -€2,904
- Taxes -€12,221
no longer reported in 2025 (was €12,221)
- Financial charges +€1,866
up €1,866 (+15.7%), from €11,864 to €13,730
- Other operating charges -€960
no longer reported in 2025 (was €960)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €840,069 | €840,071 | +€2 | 0.0% |
| Fixed assets | 21/28 | €840,000 | €840,000 | = | 0.0% |
| Financial fixed assets | 28 | €840,000 | €840,000 | = | 0.0% |
| Current assets | 29/58 | €69 | €71 | +€2 | +3.0% |
| Amounts receivable within one year | 40/41 | - | €5 | +€5 | |
| Other amounts receivable | 41 | - | €5 | +€5 | |
| Cash at bank and in hand | 54/58 | €69 | €66 | -€3 | -3.8% |
| Total equity and liabilities | 10/49 | €840,069 | €840,071 | +€2 | 0.0% |
| Equity | 10/15 | €155,833 | €139,199 | -€16,634 | -10.7% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €135,373 | €118,739 | -€16,634 | -12.3% |
| Amounts payable | 17/49 | €684,236 | €700,872 | +€16,636 | +2.4% |
| Amounts payable after more than one year | 17 | €500,211 | €457,100 | -€43,111 | -8.6% |
| Financial debts | 170/4 | €500,211 | €457,100 | -€43,111 | -8.6% |
| Amounts payable within one year | 42/48 | €184,025 | €243,772 | +€59,747 | +32.5% |
| Current portion of amounts payable after more than one year | 42 | €59,406 | €60,236 | +€830 | +1.4% |
| Trade debts | 44 | €689 | €3,760 | +€3,071 | +446% |
| Suppliers | 440/4 | €689 | €3,760 | +€3,071 | +446% |
| Taxes, remuneration and social security | 45 | €37,494 | €4,386 | -€33,108 | -88.3% |
| Taxes | 450/3 | €37,494 | €4,386 | -€33,108 | -88.3% |
| Other amounts payable | 47/48 | €86,436 | €175,389 | +€88,953 | +103% |
| Other operating charges | 640/8 | €960 | - | -€960 | |
| Gross operating margin | 9900 | €57,628 | -€2,904 | -€60,532 | |
| Operating profit (loss) | 9901 | €56,668 | -€2,904 | -€59,572 | |
| Financial charges | 65/66B | €11,864 | €13,730 | +€1,866 | +15.7% |
| Recurring financial charges | 65 | €11,864 | €13,730 | +€1,866 | +15.7% |
| Profit (loss) for the period before taxes | 9903 | €44,804 | -€16,634 | -€61,438 | |
| Income taxes | 67/77 | €12,221 | - | -€12,221 | |
| Profit (loss) for the period | 9904 | €32,583 | -€16,634 | -€49,217 | |
| Profit (loss) for the period to be appropriated | 9905 | €32,583 | -€16,634 | -€49,217 |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.